Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups

Background and Aim The metabolic syndrome (MetS) and each of its components are strongly associated with non‐alcoholic fatty liver disease (NAFLD). This has led many investigators to suggest that NAFLD is an independent component of the MetS. We formally tested this hypothesis using confirmatory fac...

Full description

Saved in:
Bibliographic Details
Published inJournal of gastroenterology and hepatology Vol. 28; no. 4; pp. 664 - 670
Main Authors Smits, Mark M, Ioannou, George N, Boyko, Edward J, Utzschneider, Kristina M
Format Journal Article
LanguageEnglish
Published Australia Blackwell Publishing Ltd 01.04.2013
Subjects
Online AccessGet full text
ISSN0815-9319
1440-1746
1440-1746
DOI10.1111/jgh.12106

Cover

Abstract Background and Aim The metabolic syndrome (MetS) and each of its components are strongly associated with non‐alcoholic fatty liver disease (NAFLD). This has led many investigators to suggest that NAFLD is an independent component of the MetS. We formally tested this hypothesis using confirmatory factor analysis, which allows comparison of different models, with or without including NAFLD as a component of the MetS. Methods We analyzed data from 3846 subjects of the Third National Health and Nutrition Examination Survey (1988–1994). NAFLD was defined by increased liver fat measured by ultrasonography. Results MetS by Adult Treatment Panel III criteria was present in 20.5%, and 30.2% had NAFLD, defined as mild, moderate, or severe ultrasonographic steatosis. Using confirmatory factor analysis, a basic model representing the MetS using its currently accepted components (glucose, waist, triglyceride/high‐density lipoprotein ratio, and mean arterial pressure) showed excellent goodness‐of‐fit statistics. Addition of NAFLD to the model as a fifth independent variable decreased model fit, suggesting that NAFLD is not an additional independent component of the MetS. Analysis by ethnicity showed that addition of NAFLD decreased model fit in Whites but resulted in minor improvements in non‐Hispanic Blacks and Mexican Americans. Conclusions The MetS is strongly associated with NAFLD. However, we found no evidence that NAFLD is an independent component or manifestation of the MetS. Interestingly, ethnic differences might be important in this relationship and require further study.
AbstractList The metabolic syndrome (MetS) and each of its components are strongly associated with non-alcoholic fatty liver disease (NAFLD). This has led many investigators to suggest that NAFLD is an independent component of the MetS. We formally tested this hypothesis using confirmatory factor analysis, which allows comparison of different models, with or without including NAFLD as a component of the MetS. We analyzed data from 3846 subjects of the Third National Health and Nutrition Examination Survey (1988-1994). NAFLD was defined by increased liver fat measured by ultrasonography. MetS by Adult Treatment Panel III criteria was present in 20.5%, and 30.2% had NAFLD, defined as mild, moderate, or severe ultrasonographic steatosis. Using confirmatory factor analysis, a basic model representing the MetS using its currently accepted components (glucose, waist, triglyceride/high-density lipoprotein ratio, and mean arterial pressure) showed excellent goodness-of-fit statistics. Addition of NAFLD to the model as a fifth independent variable decreased model fit, suggesting that NAFLD is not an additional independent component of the MetS. Analysis by ethnicity showed that addition of NAFLD decreased model fit in Whites but resulted in minor improvements in non-Hispanic Blacks and Mexican Americans. The MetS is strongly associated with NAFLD. However, we found no evidence that NAFLD is an independent component or manifestation of the MetS. Interestingly, ethnic differences might be important in this relationship and require further study.
Background and Aim The metabolic syndrome (MetS) and each of its components are strongly associated with non‐alcoholic fatty liver disease (NAFLD). This has led many investigators to suggest that NAFLD is an independent component of the MetS. We formally tested this hypothesis using confirmatory factor analysis, which allows comparison of different models, with or without including NAFLD as a component of the MetS. Methods We analyzed data from 3846 subjects of the Third National Health and Nutrition Examination Survey (1988–1994). NAFLD was defined by increased liver fat measured by ultrasonography. Results MetS by Adult Treatment Panel III criteria was present in 20.5%, and 30.2% had NAFLD, defined as mild, moderate, or severe ultrasonographic steatosis. Using confirmatory factor analysis, a basic model representing the MetS using its currently accepted components (glucose, waist, triglyceride/high‐density lipoprotein ratio, and mean arterial pressure) showed excellent goodness‐of‐fit statistics. Addition of NAFLD to the model as a fifth independent variable decreased model fit, suggesting that NAFLD is not an additional independent component of the MetS. Analysis by ethnicity showed that addition of NAFLD decreased model fit in Whites but resulted in minor improvements in non‐Hispanic Blacks and Mexican Americans. Conclusions The MetS is strongly associated with NAFLD. However, we found no evidence that NAFLD is an independent component or manifestation of the MetS. Interestingly, ethnic differences might be important in this relationship and require further study.
The metabolic syndrome (MetS) and each of its components are strongly associated with non-alcoholic fatty liver disease (NAFLD). This has led many investigators to suggest that NAFLD is an independent component of the MetS. We formally tested this hypothesis using confirmatory factor analysis, which allows comparison of different models, with or without including NAFLD as a component of the MetS.BACKGROUND AND AIMThe metabolic syndrome (MetS) and each of its components are strongly associated with non-alcoholic fatty liver disease (NAFLD). This has led many investigators to suggest that NAFLD is an independent component of the MetS. We formally tested this hypothesis using confirmatory factor analysis, which allows comparison of different models, with or without including NAFLD as a component of the MetS.We analyzed data from 3846 subjects of the Third National Health and Nutrition Examination Survey (1988-1994). NAFLD was defined by increased liver fat measured by ultrasonography.METHODSWe analyzed data from 3846 subjects of the Third National Health and Nutrition Examination Survey (1988-1994). NAFLD was defined by increased liver fat measured by ultrasonography.MetS by Adult Treatment Panel III criteria was present in 20.5%, and 30.2% had NAFLD, defined as mild, moderate, or severe ultrasonographic steatosis. Using confirmatory factor analysis, a basic model representing the MetS using its currently accepted components (glucose, waist, triglyceride/high-density lipoprotein ratio, and mean arterial pressure) showed excellent goodness-of-fit statistics. Addition of NAFLD to the model as a fifth independent variable decreased model fit, suggesting that NAFLD is not an additional independent component of the MetS. Analysis by ethnicity showed that addition of NAFLD decreased model fit in Whites but resulted in minor improvements in non-Hispanic Blacks and Mexican Americans.RESULTSMetS by Adult Treatment Panel III criteria was present in 20.5%, and 30.2% had NAFLD, defined as mild, moderate, or severe ultrasonographic steatosis. Using confirmatory factor analysis, a basic model representing the MetS using its currently accepted components (glucose, waist, triglyceride/high-density lipoprotein ratio, and mean arterial pressure) showed excellent goodness-of-fit statistics. Addition of NAFLD to the model as a fifth independent variable decreased model fit, suggesting that NAFLD is not an additional independent component of the MetS. Analysis by ethnicity showed that addition of NAFLD decreased model fit in Whites but resulted in minor improvements in non-Hispanic Blacks and Mexican Americans.The MetS is strongly associated with NAFLD. However, we found no evidence that NAFLD is an independent component or manifestation of the MetS. Interestingly, ethnic differences might be important in this relationship and require further study.CONCLUSIONSThe MetS is strongly associated with NAFLD. However, we found no evidence that NAFLD is an independent component or manifestation of the MetS. Interestingly, ethnic differences might be important in this relationship and require further study.
Author Smits, Mark M
Utzschneider, Kristina M
Boyko, Edward J
Ioannou, George N
Author_xml – sequence: 1
  givenname: Mark M
  surname: Smits
  fullname: Smits, Mark M
  organization: Division of Metabolism, Endocrinology and Nutrition, VA Puget Sound Health Care System and University of Washington, Seattle, Washington, USA
– sequence: 2
  givenname: George N
  surname: Ioannou
  fullname: Ioannou, George N
  organization: Division of Gastroenterology, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Washington, Seattle, USA
– sequence: 3
  givenname: Edward J
  surname: Boyko
  fullname: Boyko, Edward J
  organization: Epidemiologic Research and Information Center, VA Puget Sound Health Care System and University of Washington, Washington, Seattle, USA
– sequence: 4
  givenname: Kristina M
  surname: Utzschneider
  fullname: Utzschneider, Kristina M
  email: kutzschn@u.washington.edu
  organization: Division of Metabolism, Endocrinology and Nutrition, VA Puget Sound Health Care System and University of Washington, Washington, Seattle, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23286209$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1PFTEUhhuDkQuy8A-YLmUx0E6n8-HOgF4k5GIUgnHTdDpnuMVOe2k76PwO_7DlXmBhgl2cbp7nTc55d9CWdRYQekPJAU3v8OZ6eUBzSsoXaEaLgmS0KsotNCM15VnDaLONdkK4IYQUpOKv0HbO8rrMSTNDfxbOZtIot3RGK9zLGCds9B143OkAMgCWAUuLte1gBWnYiAdpdQ8hyqidxa7HcQl4gCjbdUiYbOfdAO_xVwijieEekfjyG7ZrQxocRn8HUwpNqgfAEJc2mdfejavwGr3spQmw9_DvostPHy-OTrKz8_nnow9nmSrypsxYWTOpesU6znroFJdtzQitea1ayqnKqSR1o5qG8bwoOWWMEaCk40TylpcV20XvNrkr727HtI8YdFBgjLTgxiAoywktq7oiCX37gI7tAJ1YeT1IP4nHQyZgfwMo70Lw0D8hlIj7kkQqSaxLSuzhP6zSm1tGL7X5n_FLG5iejxan85NHI9sYOkT4_WRI_1OkzSsurhZz8X1xRX4c81Pxhf0FIr6y3Q
CitedBy_id crossref_primary_10_1111_eci_14368
crossref_primary_10_1007_s11033_016_4058_z
crossref_primary_10_1016_j_jhep_2017_11_012
crossref_primary_10_1136_heartjnl_2013_305099
crossref_primary_10_1016_j_nutres_2014_04_001
crossref_primary_10_1186_1475_2891_12_96
crossref_primary_10_1093_bmb_ldw031
crossref_primary_10_1186_s12944_023_01867_3
crossref_primary_10_1186_s12876_018_0906_8
crossref_primary_10_1016_j_cld_2015_10_002
crossref_primary_10_1016_j_jhepr_2023_100964
crossref_primary_10_1111_jgh_15154
crossref_primary_10_1152_ajpendo_00207_2020
crossref_primary_10_3390_nu13030856
crossref_primary_10_1111_liv_13622
crossref_primary_10_3390_cells9071638
crossref_primary_10_1016_j_ecl_2013_09_009
crossref_primary_10_1097_MD_0000000000010214
crossref_primary_10_1111_liv_13860
crossref_primary_10_1590_0001_3765201720160394
crossref_primary_10_1097_MD_0000000000038530
crossref_primary_10_1136_bmjopen_2015_008204
crossref_primary_10_1016_j_amjms_2020_06_020
crossref_primary_10_1080_07853890_2021_1943514
crossref_primary_10_1002_oby_20624
crossref_primary_10_3390_ijms17030367
crossref_primary_10_1007_s10620_016_4143_0
crossref_primary_10_1111_jgh_12432
crossref_primary_10_1007_s11695_021_05797_w
crossref_primary_10_1007_s40265_015_0437_3
crossref_primary_10_1007_s00345_014_1392_4
crossref_primary_10_1155_2018_8597897
crossref_primary_10_1016_j_dld_2021_05_022
crossref_primary_10_2139_ssrn_4118388
crossref_primary_10_1016_j_clnesp_2020_04_004
crossref_primary_10_33590_emj_10310531
crossref_primary_10_1016_j_jcmgh_2018_09_017
crossref_primary_10_1080_17474124_2017_1355731
crossref_primary_10_1186_s12902_021_00719_4
crossref_primary_10_3748_wjg_v22_i32_7236
crossref_primary_10_1007_s11596_022_2573_9
crossref_primary_10_1016_j_jacl_2016_09_007
crossref_primary_10_54307_2024_NWMJ_95
crossref_primary_10_1080_07315724_2018_1443292
crossref_primary_10_1002_hep_27242
crossref_primary_10_1016_j_juro_2018_03_135
crossref_primary_10_1111_jgh_12935
crossref_primary_10_3390_app132111747
crossref_primary_10_1136_bmjopen_2022_070431
crossref_primary_10_1371_journal_pone_0096651
crossref_primary_10_1002_oby_23438
crossref_primary_10_1111_1751_2980_12341
crossref_primary_10_15436_2378_6841_18_1561
crossref_primary_10_1186_s12902_022_00993_w
crossref_primary_10_14260_jemds_2016_166
crossref_primary_10_1016_j_cca_2016_07_003
crossref_primary_10_4254_wjh_v6_i5_274
crossref_primary_10_1111_resp_13127
crossref_primary_10_1080_00325481_2019_1546532
crossref_primary_10_3390_nu9060540
crossref_primary_10_3389_fpsyt_2024_1343427
crossref_primary_10_33590_emjhepatol_10311541
crossref_primary_10_1038_nature13478
crossref_primary_10_1586_17474124_2015_1003209
crossref_primary_10_1186_s12876_023_02864_7
crossref_primary_10_1016_j_pan_2020_08_011
crossref_primary_10_1038_srep27034
crossref_primary_10_1007_s00774_015_0687_x
crossref_primary_10_1111_apt_14327
crossref_primary_10_1093_function_zqab001
crossref_primary_10_1002_mgg3_168
crossref_primary_10_1097_MCG_0000000000001229
crossref_primary_10_1016_j_cgh_2015_05_001
crossref_primary_10_1097_MD_0000000000000907
crossref_primary_10_1016_j_cld_2017_08_008
crossref_primary_10_1097_MEG_0000000000000598
crossref_primary_10_1016_j_cld_2017_08_006
crossref_primary_10_1371_journal_pone_0165970
crossref_primary_10_3748_wjg_v20_i47_17839
crossref_primary_10_1089_bari_2016_0018
crossref_primary_10_1016_j_cld_2017_08_001
crossref_primary_10_1016_j_jhep_2023_03_017
crossref_primary_10_1074_jbc_M116_728949
crossref_primary_10_3748_wjg_v21_i14_4103
crossref_primary_10_1007_s10620_015_3983_3
crossref_primary_10_1042_CS20150308
crossref_primary_10_1186_s40364_017_0096_5
crossref_primary_10_1016_j_dld_2014_09_020
crossref_primary_10_1111_obr_13481
crossref_primary_10_1152_ajpendo_00345_2017
crossref_primary_10_1007_s11894_016_0485_1
crossref_primary_10_1002_cam4_2777
crossref_primary_10_1097_HEP_0000000000000323
crossref_primary_10_1111_bju_14753
crossref_primary_10_1016_j_redox_2016_09_002
crossref_primary_10_3390_cells11203227
crossref_primary_10_1016_j_jpeds_2020_01_031
crossref_primary_10_11569_wcjd_v30_i11_465
crossref_primary_10_3390_cimb44050129
crossref_primary_10_1038_nrgastro_2017_109
crossref_primary_10_3803_EnM_2019_34_2_179
crossref_primary_10_3390_ijms22084241
crossref_primary_10_1016_j_gene_2024_148660
crossref_primary_10_12688_wellcomeopenres_12199_1
crossref_primary_10_1186_s40168_021_01125_7
Cites_doi 10.1002/hep.24726
10.1016/j.jacc.2006.09.032
10.1016/j.metabol.2011.09.003
10.7326/0003-4819-143-10-200511150-00009
10.1161/CIRCULATIONAHA.105.559633
10.1016/j.cld.2009.02.009
10.2337/dc09-2049
10.1159/000090173
10.2337/diabetes.50.8.1844
10.1111/j.1440-1746.2010.06542.x
10.1016/j.atherosclerosis.2006.12.018
10.2337/diacare.26.11.3153
10.1007/s00125-007-0651-y
10.2337/diacare.27.5.1182
10.1161/01.ATV.17.11.2413
10.2337/diacare.29.01.06.dc05-0862
10.1056/NEJM199909023411002
10.3748/wjg.14.185
10.1037/10694-000
10.1111/j.1751-2980.2011.00487.x
10.1002/hep.24452
10.1001/jama.287.3.356
10.2337/diab.45.6.742
10.1002/hep.20466
10.1055/s-2004-823098
10.1002/hep.25539
10.1007/BF00280883
10.1053/j.gastro.2007.11.038
10.1001/archinte.163.4.427
10.1093/aje/kwh150
10.1073/pnas.0904944106
10.1136/bmj.d6891
10.1111/j.1440-1746.2006.04698.x
10.3748/wjg.14.2474
ContentType Journal Article
Copyright Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
Copyright_xml – notice: Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/jgh.12106
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1440-1746
EndPage 670
ExternalDocumentID 23286209
10_1111_jgh_12106
JGH12106
ark_67375_WNG_XNW0ZD5J_P
Genre article
Research Support, U.S. Gov't, Non-P.H.S
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
29K
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEGXH
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHEFC
AIACR
AIDQK
AIDYY
AIQQE
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
D-I
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DTERQ
DU5
EBS
EJD
EMOBN
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
KMS
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WOHZO
WOQ
WOW
WQJ
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAHHS
ACCFJ
AEEZP
AEQDE
AEUQT
AFPWT
AIWBW
AJBDE
ESX
WRC
WUP
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c4296-3683acfc3d53fedc5ab8301858cb151c21a089c9935246513330e10d50a5b5673
IEDL.DBID DR2
ISSN 0815-9319
1440-1746
IngestDate Wed Oct 01 14:07:25 EDT 2025
Mon Jul 21 06:06:06 EDT 2025
Wed Oct 01 02:28:55 EDT 2025
Thu Apr 24 23:09:19 EDT 2025
Wed Jan 22 16:51:33 EST 2025
Sun Sep 21 06:20:08 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4296-3683acfc3d53fedc5ab8301858cb151c21a089c9935246513330e10d50a5b5673
Notes ark:/67375/WNG-XNW0ZD5J-P
istex:C6A40953873BFB404E9550E89E3C0DC5F18504D9
ArticleID:JGH12106
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 23286209
PQID 1320167870
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_1320167870
pubmed_primary_23286209
crossref_primary_10_1111_jgh_12106
crossref_citationtrail_10_1111_jgh_12106
wiley_primary_10_1111_jgh_12106_JGH12106
istex_primary_ark_67375_WNG_XNW0ZD5J_P
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2013
PublicationDateYYYYMMDD 2013-04-01
PublicationDate_xml – month: 04
  year: 2013
  text: April 2013
PublicationDecade 2010
PublicationPlace Australia
PublicationPlace_xml – name: Australia
PublicationTitle Journal of gastroenterology and hepatology
PublicationTitleAlternate J Gastroenterol Hepatol
PublicationYear 2013
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References Donahue RP, Bean JA, Donahue RD, Goldberg RB, Prineas RJ. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2413-2417.
Hanley AJ, Karter AJ, Williams K et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation 2005; 112: 3713-3721.
Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 2003; 163: 427-436.
Hwang SJ, Lee SD. Hepatic steatosis and hepatitis C: still unhappy bedfellows? J. Gastroenterol. Hepatol. 2011; 26 (Suppl. 1): 96-101.
Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003; 26: 3153-3159.
Browning JD, Szczepaniak LS, Dobbins R et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395.
Brunt EM. Nonalcoholic steatohepatitis. Semin. Liver Dis. 2004; 24: 3-20.
Gami AS, Witt BJ, Howard DE et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 2007; 49: 403-414.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
Lomonaco R, Ortiz-Lopez C, Orsak B et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 2011; 55: 1389-1397.
Bambha K, Belt P, Abraham M et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology 2012; 55: 769-780.
Younossi ZM, Otgonsuren M, Venkatesan C, Mishra A. In patients with non-alcoholic fatty liver disease (NAFLD), metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism 2012.
Marchesini G, Brizi M, Bianchi G et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850.
Lawlor DA, Ebrahim S, May M, Davey SG. (Mis)use of factor analysis in the study of insulin resistance syndrome. Am. J. Epidemiol. 2004; 159: 1013-1018.
Martinez-Vizcaino V, Martinez MS, Aguilar FS et al. Validity of a single-factor model underlying the metabolic syndrome in children: a confirmatory factor analysis. Diabetes Care 2010; 33: 1370-1372.
Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis 2008; 196: 696-703.
Fabbrini E, Magkos F, Mohammed BS et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. U. S. A. 2009; 106: 15430-15435.
Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27: 1182-1186.
Hernaez R, Lazo M, Bonekamp S et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011; 54: 1082-1090.
Hamaguchi M, Kojima T, Takeda N et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med. 2005; 143: 722-728.
Hsiao PJ, Kuo KK, Shin SJ et al. Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J. Gastroenterol. Hepatol. 2007; 22: 2118-2123.
Adachi M, Brenner DA. Clinical syndromes of alcoholic liver disease. Dig. Dis. 2005; 23: 255-263.
Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 2008; 134: 424-431.
Dagogo-Jack S. Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management. J. Natl Med. Assoc. 2003; 95: 774, 779-89.
Haffner SM, D'Agostino R, Saad MF et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996; 45: 742-748.
Lazo M, Hernaez R, Bonekamp S et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011; 343: d6891.
Tong J, Boyko EJ, Utzschneider KM et al. Intra-abdominal fat accumulation predicts the development of the metabolic syndrome in non-diabetic Japanese-Americans. Diabetologia 2007; 50: 1156-1160.
Pladevall M, Singal B, Williams LK et al. A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care 2006; 29: 113-122.
Deboer MD, Dong L, Gurka MJ. Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999-2006. Metabolism 2011; 61: 554-561.
McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 2006; 40 (Suppl. 1): S17-29.
Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J. Dig. Dis. 2011; 12: 125-130.
Schreuder TC, Verwer BJ, van Nieuwkerk CM, Mulder CJ. Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment. World J. Gastroenterol. 2008; 14: 2474-2486.
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
Rafiq N, Younossi ZM. Nonalcoholic fatty liver disease: a practical approach to evaluation and management. Clin. Liver Dis. 2009; 13: 249-266.
Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J. Gastroenterol. 2008; 14: 185-192.
Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N. Engl. J. Med. 1999; 341: 718-724.
Thompson B. Exploratory and Confirmatory Factor Analysis. Washington, DC: American Psychological Association, 2004.
2010; 33
1985; 28
2001; 50
2004; 40
2012
2010
2005; 112
2004; 27
2004; 24
2011; 61
2008; 14
1999; 341
1996
2011; 55
2011; 54
1994
2007; 50
2011; 12
2004
2003; 95
2012; 55
2005; 23
2009; 13
2004; 159
2006; 40
2005; 143
2002; 287
2003; 26
1997; 17
2006; 29
2011; 26
2008; 134
2007; 22
2011; 343
2008; 196
1996; 45
2007; 49
2003; 163
2009; 106
e_1_2_6_32_1
e_1_2_6_10_1
e_1_2_6_31_1
e_1_2_6_30_1
Dagogo‐Jack S (e_1_2_6_37_1) 2003; 95
e_1_2_6_19_1
e_1_2_6_13_1
e_1_2_6_36_1
e_1_2_6_14_1
e_1_2_6_35_1
e_1_2_6_11_1
e_1_2_6_12_1
e_1_2_6_33_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_39_1
e_1_2_6_15_1
e_1_2_6_38_1
e_1_2_6_16_1
e_1_2_6_42_1
e_1_2_6_21_1
e_1_2_6_20_1
e_1_2_6_41_1
e_1_2_6_40_1
McCullough AJ (e_1_2_6_7_1) 2006; 40
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_6_1
e_1_2_6_25_1
Younossi ZM (e_1_2_6_34_1) 2012
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_22_1
e_1_2_6_29_1
e_1_2_6_28_1
e_1_2_6_27_1
e_1_2_6_26_1
References_xml – reference: Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 2003; 163: 427-436.
– reference: Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003; 26: 3153-3159.
– reference: Pladevall M, Singal B, Williams LK et al. A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care 2006; 29: 113-122.
– reference: Dagogo-Jack S. Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management. J. Natl Med. Assoc. 2003; 95: 774, 779-89.
– reference: Martinez-Vizcaino V, Martinez MS, Aguilar FS et al. Validity of a single-factor model underlying the metabolic syndrome in children: a confirmatory factor analysis. Diabetes Care 2010; 33: 1370-1372.
– reference: Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
– reference: Thompson B. Exploratory and Confirmatory Factor Analysis. Washington, DC: American Psychological Association, 2004.
– reference: Fabbrini E, Magkos F, Mohammed BS et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. U. S. A. 2009; 106: 15430-15435.
– reference: Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J. Gastroenterol. 2008; 14: 185-192.
– reference: Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J. Dig. Dis. 2011; 12: 125-130.
– reference: Gami AS, Witt BJ, Howard DE et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 2007; 49: 403-414.
– reference: Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27: 1182-1186.
– reference: Schreuder TC, Verwer BJ, van Nieuwkerk CM, Mulder CJ. Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment. World J. Gastroenterol. 2008; 14: 2474-2486.
– reference: Marchesini G, Brizi M, Bianchi G et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850.
– reference: Brunt EM. Nonalcoholic steatohepatitis. Semin. Liver Dis. 2004; 24: 3-20.
– reference: Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis 2008; 196: 696-703.
– reference: Hernaez R, Lazo M, Bonekamp S et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011; 54: 1082-1090.
– reference: Donahue RP, Bean JA, Donahue RD, Goldberg RB, Prineas RJ. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2413-2417.
– reference: Hanley AJ, Karter AJ, Williams K et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation 2005; 112: 3713-3721.
– reference: Younossi ZM, Otgonsuren M, Venkatesan C, Mishra A. In patients with non-alcoholic fatty liver disease (NAFLD), metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism 2012.
– reference: Deboer MD, Dong L, Gurka MJ. Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999-2006. Metabolism 2011; 61: 554-561.
– reference: Lawlor DA, Ebrahim S, May M, Davey SG. (Mis)use of factor analysis in the study of insulin resistance syndrome. Am. J. Epidemiol. 2004; 159: 1013-1018.
– reference: McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 2006; 40 (Suppl. 1): S17-29.
– reference: Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
– reference: Adachi M, Brenner DA. Clinical syndromes of alcoholic liver disease. Dig. Dis. 2005; 23: 255-263.
– reference: Tong J, Boyko EJ, Utzschneider KM et al. Intra-abdominal fat accumulation predicts the development of the metabolic syndrome in non-diabetic Japanese-Americans. Diabetologia 2007; 50: 1156-1160.
– reference: Lomonaco R, Ortiz-Lopez C, Orsak B et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 2011; 55: 1389-1397.
– reference: Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 2008; 134: 424-431.
– reference: Lazo M, Hernaez R, Bonekamp S et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011; 343: d6891.
– reference: Hsiao PJ, Kuo KK, Shin SJ et al. Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J. Gastroenterol. Hepatol. 2007; 22: 2118-2123.
– reference: Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N. Engl. J. Med. 1999; 341: 718-724.
– reference: Bambha K, Belt P, Abraham M et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology 2012; 55: 769-780.
– reference: Hamaguchi M, Kojima T, Takeda N et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med. 2005; 143: 722-728.
– reference: Rafiq N, Younossi ZM. Nonalcoholic fatty liver disease: a practical approach to evaluation and management. Clin. Liver Dis. 2009; 13: 249-266.
– reference: Browning JD, Szczepaniak LS, Dobbins R et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395.
– reference: Hwang SJ, Lee SD. Hepatic steatosis and hepatitis C: still unhappy bedfellows? J. Gastroenterol. Hepatol. 2011; 26 (Suppl. 1): 96-101.
– reference: Haffner SM, D'Agostino R, Saad MF et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996; 45: 742-748.
– volume: 14
  start-page: 185
  year: 2008
  end-page: 192
  article-title: Non‐alcoholic fatty liver disease and the metabolic syndrome: an update
  publication-title: World J. Gastroenterol.
– volume: 28
  start-page: 412
  year: 1985
  end-page: 419
  article-title: Homeostasis model assessment: insulin resistance and beta‐cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
– year: 2012
  article-title: In patients with non‐alcoholic fatty liver disease (NAFLD), metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not
  publication-title: Metabolism
– volume: 159
  start-page: 1013
  year: 2004
  end-page: 1018
  article-title: (Mis)use of factor analysis in the study of insulin resistance syndrome
  publication-title: Am. J. Epidemiol.
– volume: 50
  start-page: 1844
  year: 2001
  end-page: 1850
  article-title: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome
  publication-title: Diabetes
– volume: 343
  start-page: d6891
  year: 2011
  article-title: Non‐alcoholic fatty liver disease and mortality among US adults: prospective cohort study
  publication-title: BMJ
– volume: 22
  start-page: 2118
  year: 2007
  end-page: 2123
  article-title: Significant correlations between severe fatty liver and risk factors for metabolic syndrome
  publication-title: J. Gastroenterol. Hepatol.
– volume: 26
  start-page: 3153
  year: 2003
  end-page: 3159
  article-title: The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study
  publication-title: Diabetes Care
– year: 1996
– volume: 23
  start-page: 255
  year: 2005
  end-page: 263
  article-title: Clinical syndromes of alcoholic liver disease
  publication-title: Dig. Dis.
– volume: 287
  start-page: 356
  year: 2002
  end-page: 359
  article-title: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey
  publication-title: JAMA
– volume: 50
  start-page: 1156
  year: 2007
  end-page: 1160
  article-title: Intra‐abdominal fat accumulation predicts the development of the metabolic syndrome in non‐diabetic Japanese‐Americans
  publication-title: Diabetologia
– volume: 40
  start-page: S17
  year: 2006
  end-page: 29
  article-title: Pathophysiology of nonalcoholic steatohepatitis
  publication-title: J. Clin. Gastroenterol.
– volume: 17
  start-page: 2413
  year: 1997
  end-page: 2417
  article-title: Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 95
  start-page: 774
  year: 2003
  article-title: Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management
  publication-title: J. Natl Med. Assoc.
– volume: 13
  start-page: 249
  year: 2009
  end-page: 266
  article-title: Nonalcoholic fatty liver disease: a practical approach to evaluation and management
  publication-title: Clin. Liver Dis.
– volume: 112
  start-page: 3713
  year: 2005
  end-page: 3721
  article-title: Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study
  publication-title: Circulation
– year: 1994
– year: 2010
– volume: 143
  start-page: 722
  year: 2005
  end-page: 728
  article-title: The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
  publication-title: Ann. Intern. Med.
– volume: 341
  start-page: 718
  year: 1999
  end-page: 724
  article-title: A population‐based study of the clinical expression of the hemochromatosis gene
  publication-title: N. Engl. J. Med.
– volume: 61
  start-page: 554
  year: 2011
  end-page: 561
  article-title: Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999–2006
  publication-title: Metabolism
– volume: 163
  start-page: 427
  year: 2003
  end-page: 436
  article-title: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994
  publication-title: Arch. Intern. Med.
– volume: 12
  start-page: 125
  year: 2011
  end-page: 130
  article-title: Relationship between nonalcoholic fatty liver disease and metabolic syndrome
  publication-title: J. Dig. Dis.
– year: 2004
– volume: 40
  start-page: 1387
  year: 2004
  end-page: 1395
  article-title: Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity
  publication-title: Hepatology
– volume: 196
  start-page: 696
  year: 2008
  end-page: 703
  article-title: Ethnic differences in the ability of triglyceride levels to identify insulin resistance
  publication-title: Atherosclerosis
– volume: 55
  start-page: 1389
  year: 2011
  end-page: 1397
  article-title: Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
  publication-title: Hepatology
– volume: 26
  start-page: 96
  issue: Suppl. 1
  year: 2011
  end-page: 101
  article-title: Hepatic steatosis and hepatitis C: still unhappy bedfellows?
  publication-title: J. Gastroenterol. Hepatol.
– volume: 54
  start-page: 1082
  year: 2011
  end-page: 1090
  article-title: Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta‐analysis
  publication-title: Hepatology
– volume: 134
  start-page: 424
  year: 2008
  end-page: 431
  article-title: Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease
  publication-title: Gastroenterology
– volume: 33
  start-page: 1370
  year: 2010
  end-page: 1372
  article-title: Validity of a single‐factor model underlying the metabolic syndrome in children: a confirmatory factor analysis
  publication-title: Diabetes Care
– volume: 14
  start-page: 2474
  year: 2008
  end-page: 2486
  article-title: Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment
  publication-title: World J. Gastroenterol.
– volume: 106
  start-page: 15430
  year: 2009
  end-page: 15435
  article-title: Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 27
  start-page: 1182
  year: 2004
  end-page: 1186
  article-title: Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?
  publication-title: Diabetes Care
– volume: 45
  start-page: 742
  year: 1996
  end-page: 748
  article-title: Increased insulin resistance and insulin secretion in nondiabetic African‐Americans and Hispanics compared with non‐Hispanic whites. The Insulin Resistance Atherosclerosis Study
  publication-title: Diabetes
– volume: 49
  start-page: 403
  year: 2007
  end-page: 414
  article-title: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta‐analysis of longitudinal studies
  publication-title: J. Am. Coll. Cardiol.
– volume: 24
  start-page: 3
  year: 2004
  end-page: 20
  article-title: Nonalcoholic steatohepatitis
  publication-title: Semin. Liver Dis.
– volume: 29
  start-page: 113
  year: 2006
  end-page: 122
  article-title: A single factor underlies the metabolic syndrome: a confirmatory factor analysis
  publication-title: Diabetes Care
– volume: 55
  start-page: 769
  year: 2012
  end-page: 780
  article-title: Ethnicity and nonalcoholic fatty liver disease
  publication-title: Hepatology
– ident: e_1_2_6_28_1
  doi: 10.1002/hep.24726
– ident: e_1_2_6_20_1
– ident: e_1_2_6_26_1
– ident: e_1_2_6_2_1
  doi: 10.1016/j.jacc.2006.09.032
– ident: e_1_2_6_41_1
  doi: 10.1016/j.metabol.2011.09.003
– ident: e_1_2_6_8_1
  doi: 10.7326/0003-4819-143-10-200511150-00009
– ident: e_1_2_6_25_1
  doi: 10.1161/CIRCULATIONAHA.105.559633
– ident: e_1_2_6_13_1
  doi: 10.1016/j.cld.2009.02.009
– year: 2012
  ident: e_1_2_6_34_1
  article-title: In patients with non‐alcoholic fatty liver disease (NAFLD), metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not
  publication-title: Metabolism
– ident: e_1_2_6_16_1
  doi: 10.2337/dc09-2049
– ident: e_1_2_6_18_1
  doi: 10.1159/000090173
– volume: 40
  start-page: S17
  year: 2006
  ident: e_1_2_6_7_1
  article-title: Pathophysiology of nonalcoholic steatohepatitis
  publication-title: J. Clin. Gastroenterol.
– ident: e_1_2_6_11_1
  doi: 10.2337/diabetes.50.8.1844
– ident: e_1_2_6_19_1
  doi: 10.1111/j.1440-1746.2010.06542.x
– ident: e_1_2_6_38_1
  doi: 10.1016/j.atherosclerosis.2006.12.018
– ident: e_1_2_6_3_1
  doi: 10.2337/diacare.26.11.3153
– ident: e_1_2_6_4_1
  doi: 10.1007/s00125-007-0651-y
– ident: e_1_2_6_36_1
  doi: 10.2337/diacare.27.5.1182
– ident: e_1_2_6_5_1
  doi: 10.1161/01.ATV.17.11.2413
– ident: e_1_2_6_15_1
  doi: 10.2337/diacare.29.01.06.dc05-0862
– ident: e_1_2_6_17_1
– ident: e_1_2_6_23_1
  doi: 10.1056/NEJM199909023411002
– ident: e_1_2_6_12_1
  doi: 10.3748/wjg.14.185
– ident: e_1_2_6_14_1
  doi: 10.1037/10694-000
– ident: e_1_2_6_9_1
  doi: 10.1111/j.1751-2980.2011.00487.x
– ident: e_1_2_6_42_1
  doi: 10.1002/hep.24452
– ident: e_1_2_6_39_1
  doi: 10.1001/jama.287.3.356
– ident: e_1_2_6_40_1
  doi: 10.2337/diab.45.6.742
– volume: 95
  start-page: 774
  year: 2003
  ident: e_1_2_6_37_1
  article-title: Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management
  publication-title: J. Natl Med. Assoc.
– ident: e_1_2_6_35_1
  doi: 10.1002/hep.20466
– ident: e_1_2_6_24_1
– ident: e_1_2_6_6_1
  doi: 10.1055/s-2004-823098
– ident: e_1_2_6_30_1
  doi: 10.1002/hep.25539
– ident: e_1_2_6_21_1
  doi: 10.1007/BF00280883
– ident: e_1_2_6_31_1
  doi: 10.1053/j.gastro.2007.11.038
– ident: e_1_2_6_29_1
  doi: 10.1001/archinte.163.4.427
– ident: e_1_2_6_27_1
  doi: 10.1093/aje/kwh150
– ident: e_1_2_6_32_1
  doi: 10.1073/pnas.0904944106
– ident: e_1_2_6_22_1
  doi: 10.1136/bmj.d6891
– ident: e_1_2_6_10_1
  doi: 10.1111/j.1440-1746.2006.04698.x
– ident: e_1_2_6_33_1
  doi: 10.3748/wjg.14.2474
SSID ssj0004075
Score 2.4236646
Snippet Background and Aim The metabolic syndrome (MetS) and each of its components are strongly associated with non‐alcoholic fatty liver disease (NAFLD). This has...
The metabolic syndrome (MetS) and each of its components are strongly associated with non-alcoholic fatty liver disease (NAFLD). This has led many...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 664
SubjectTerms Adult
Cross-Sectional Studies
factor analysis
Factor Analysis, Statistical
Fatty Liver - diagnostic imaging
Fatty Liver - etiology
Female
Health Surveys
Humans
insulin resistance
Male
Metabolic Syndrome - complications
Metabolic Syndrome - diagnostic imaging
Middle Aged
NAFLD
Non-alcoholic Fatty Liver Disease
Nutrition Surveys
obesity
Prevalence
Regression Analysis
Sensitivity and Specificity
Ultrasonography
United States - epidemiology
Title Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups
URI https://api.istex.fr/ark:/67375/WNG-XNW0ZD5J-P/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjgh.12106
https://www.ncbi.nlm.nih.gov/pubmed/23286209
https://www.proquest.com/docview/1320167870
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 0815-9319
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1440-1746
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0004075
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqVqq4QCmvpRQNCCEuqfJYJ1l6qoB2tVJXqLDqCiFZtuN0qy7ZauMg2hM_gQt_kF_CjPOAoiIhbjmMLSf-Jv7GHn_D2LNBnuWk-eLJJFReP1HSUzyVXuKT9joG0EFO-x2H43g46Y-mfLrCdtu7MLU-RLfhRp7h_tfk4FKVvzv5yYykEZzcdhDFLpw6-iUd1a9FdnHF494AcdaoCrksnrbllbVojT7rl-uI5lXe6hae_VvsYzvkOt_kbKeyakdf_qHm-J_vtMFuNoQU9moE3WYrpthk64fNkfsd9n28KH58_SbrUrqnGnJp7QXMKZ8DmuMdkCXIAk67kroWSFYjN2V90A-LHJBowidjEXPUSSuU8BKOTFnNbUkmEibvoN2dhLJafjYX2Ck2XRoDxs4KbOmuoZR32WT_zftXQ6-p5eBpXPFiL4rTSOpcRxmPcpNpLlWKQEh5qhWSDh0G0k8HGtkSD6k8O8HEBH7GfckVj5PoHlstFoV5wICHcdaXkclITFD5WZrg9JooRCqHwapMe-xFO6tCN0LnVG9jLrqA52Qm3Gfusaed6Xmt7nGd0XMHjc5CLs8oHS7h4nh8IKbjY__Daz4Sb3vsSYsdgU5KJy-yMIuqFHRPPYjp39hj92tQdb0hpcWo0h_gsB00_j4QMToYuoeH_266xW6EroAH5Ro9Yqt2WZltpFFWPXb-8hM0ARgb
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB1VrQRcoHy1CwUMQohLqmwSJ1nEBQHtsnQjVLrqCglZtuN0qy5ZtEkQ5cRP4MIf5Jcw43xAUZEQtxzGlmO_sZ_t8RuAh4MszUjzxZGRp5wgUtJRPJZO5JL2Om6g-xmdd4yTcDgJRlM-XYGn7VuYWh-iO3Ajz7DzNTk4HUj_7uVHM9JGIL3ttSDEfQpRov1f4lFBLbOLax53Boi0RlfIxvG0Rc-sRmvUsZ_Po5pnmatdenauwPu20XXEycl2Vapt_eUPPcf__at1uNxwUvasBtFVWDH5Nbgwbm7dr8P3ZJH_-PpN1tl0jzXLZFmesjmFdLDmhofJgsmcHXdZdUtGyhqZKeq7frbIGHJN9sGUCDuqpNVKeML2TVHNy4JMJJu8Ze0BJSuq5SdzipVi0aUxzJSzHEvalyjFDZjsvDx4PnSadA6OxkUvdPww9qXOtJ9yPzOp5lLFiIWYx1oh79BeX7rxQCNh4h5laCekmL6bcldyxcPIvwmr-SI3m8C4F6aB9E1KeoLKTeMIx9f4HrI5xIGMe_C4HVahG61zSrkxF92e52gmbDf34EFn-rEW-DjP6JHFRmchlycUERdxcZjsimly6L57wUfiTQ_ut-AR6Kd0-SJzs6gKQU_V-yFNjz3YqFHV1YasFjeW7gCbbbHx94aI0e7Qftz6d9N7cHF4MN4Te6-S17fhkmfzeVDo0RaslsvK3EFWVaq71nl-ArJpHDw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWqVqrYQHkPFDAIITapMkmcR8UGMUyHgUZVYdRRJWQ5jt2pOmSqiVNRVnwCG36QL-Fe5wFFRULssri2HPtc-9i-PpeQp4nONWq-OCLyMieIMuFkLBZO5KL2Omyg-xrPO3bTcDQJxlM2XSEv2rcwtT5Ed-CGnmHna3RwdZrr3738aIbaCKi3vRawJMaAvsH-L_GooJbZhTWPOQkgrdEVsnE8bdELq9Eaduzny6jmReZql57hNfKxbXQdcXKyVZlsS375Q8_xf_9qg1xtOCl9WYPoOllRxQ2yvtvcut8k39NF8ePrN1Fn0z2WVAtjzukcQzpoc8NDRUlFQY-7rLqGorKGVmV9108XmgLXpJ-UAdhhJa1WwjbdV2U1NyWaCDp5T9sDSlpWyzN1DpVC0aVSVJlZASXtS5TyFpkMX394NXKadA6OhEUvdPww9oXU0s-Zr1UumchiwELMYpkB75BeX7hxIoEwMQ8ztCNSVN_NmStYxsLIv01Wi0Wh7hLKvDAPhK9y1BPM3DyOYHyV7wGbg_2qiHvkeTusXDZa55hyY867Pc_RjNtu7pEnnelpLfBxmdEzi43OQixPMCIuYvwg3eHT9MA9HLAx3-uRxy14OPgpXr6IQi2qkuNT9X6I02OP3KlR1dUGrBY2lm4CzbbY-HtD-HhnZD_u_bvpI7K-Nxjyd2_St_fJFc-m88DIo02yapaVegCkymQPre_8BDR2G8A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Non%E2%80%90alcoholic+fatty+liver+disease+as+an+independent+manifestation+of+the+metabolic+syndrome%3A+Results+of+a+US+national+survey+in+three+ethnic+groups&rft.jtitle=Journal+of+gastroenterology+and+hepatology&rft.au=Smits%2C+Mark+M&rft.au=Ioannou%2C+George+N&rft.au=Boyko%2C+Edward+J&rft.au=Utzschneider%2C+Kristina+M&rft.date=2013-04-01&rft.issn=0815-9319&rft.eissn=1440-1746&rft.volume=28&rft.issue=4&rft.spage=664&rft.epage=670&rft_id=info:doi/10.1111%2Fjgh.12106&rft.externalDBID=10.1111%252Fjgh.12106&rft.externalDocID=JGH12106
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0815-9319&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0815-9319&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0815-9319&client=summon